For example, EGFR and KRAS mutations are reported to be mutually exclusive in non-small cell lung carcinoma [26], which means that genes selected by their correlation with EGFR mutation status may be not regulated by EGFR, but instead regulated by KRAS. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.